IP Verse

Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer - EP3177645

PATENT ANALYSIS

Patent Details

Grant Date
Feb 17, 2021
Company
LINDHOFER, HORST, DR.
Oppositions

ABBVIE INC.

BOEHRINGER INGELHEIM RCV GMBH & CO KG / BOEHRINGER INGELHEIM INTERNATIONAL GMBH

DR. H. ULRICH DORRIES

F. HOFFMANN-LA ROCHE AG / GENENTECH, INC.

GENMAB A/S

JAMES POOLE LIMITED

JANSSEN BIOTECH, INC.

LAVA THERAPEUTICS N.V.

MORPHOSYS AG

REGENERON PHARMACEUTICALS, INC.

More patents of Lindhofer, Horst, Dr.

EP3177645

Want to monitor this patent?

Feel free to send us a message here and we will get back to you